Detalles de la búsqueda
1.
Local-Regional Recurrence After Neoadjuvant Endocrine Therapy: Data from ACOSOG Z1031 (Alliance), a Randomized Phase 2 Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women with Estrogen Receptor-Positive Clinical Stage 2 or 3 Breast Cancer.
Ann Surg Oncol
; 30(4): 2111-2118, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36653664
2.
Health-related quality of life outcomes for the LEAP study-CALGB 70305 (Alliance): A lymphedema prevention intervention trial for newly diagnosed breast cancer patients.
Cancer
; 127(2): 300-309, 2021 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33079393
3.
A randomized study to prevent lymphedema in women treated for breast cancer: CALGB 70305 (Alliance).
Cancer
; 127(2): 291-299, 2021 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33079411
4.
Clinical Trials for the Surgical Oncologist: Opportunities and Hurdles.
Ann Surg Oncol
; 27(7): 2269-2275, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32318946
5.
Pathogenic and likely pathogenic variants in PALB2, CHEK2, and other known breast cancer susceptibility genes among 1054 BRCA-negative Hispanics with breast cancer.
Cancer
; 125(16): 2829-2836, 2019 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31206626
6.
Hispanic breast cancer patients' symptom experience and patient-physician communication during chemotherapy.
Support Care Cancer
; 27(2): 697-704, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30062584
7.
ASO Visual Abstract: Local-Regional Recurrence Following Neoadjuvant Endocrine Therapy - Data from ACOSOG Z1031 (Alliance), a Randomized Phase II Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women with Estrogen Receptor-Positive Clinical Stage 2-3 Breast Cancer.
Ann Surg Oncol
; 30(4): 2119-2120, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36745260
8.
Whole-genome analysis informs breast cancer response to aromatase inhibition.
Nature
; 486(7403): 353-60, 2012 Jun 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-22722193
9.
Fluorouracil, epirubicin, and cyclophosphamide (FEC-75) followed by paclitaxel plus trastuzumab versus paclitaxel plus trastuzumab followed by FEC-75 plus trastuzumab as neoadjuvant treatment for patients with HER2-positive breast cancer (Z1041): a randomised, controlled, phase 3 trial.
Lancet Oncol
; 14(13): 1317-25, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24239210
10.
Endocrine-Sensitive Disease Rate in Postmenopausal Patients With Estrogen Receptor-Rich/ERBB2-Negative Breast Cancer Receiving Neoadjuvant Anastrozole, Fulvestrant, or Their Combination: A Phase 3 Randomized Clinical Trial.
JAMA Oncol
; 10(3): 362-371, 2024 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38236590
11.
The Influence of Vitamin D on Mammographic Density: Results from CALGB 70806 (Alliance) a Randomized Clinical Trial.
Cancer Prev Res (Phila)
; 14(7): 753-762, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33849913
12.
Disease-Free and Overall Survival Among Patients With Operable HER2-Positive Breast Cancer Treated With Sequential vs Concurrent Chemotherapy: The ACOSOG Z1041 (Alliance) Randomized Clinical Trial.
JAMA Oncol
; 5(1): 45-50, 2019 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30193295
13.
Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance).
J Clin Oncol
; 35(10): 1061-1069, 2017 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28045625
14.
Effect of Vitamin D Supplementation on Breast Cancer Biomarkers: CALGB 70806 (Alliance) Study Design and Baseline Data.
Am J Hematol Oncol
; 12(7): 4-9, 2016 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-29081880
15.
Prevalence and type of BRCA mutations in Hispanics undergoing genetic cancer risk assessment in the southwestern United States: a report from the Clinical Cancer Genetics Community Research Network.
J Clin Oncol
; 31(2): 210-6, 2013 Jan 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-23233716
16.
American College of Surgeons Oncology Group and the community surgeon.
Surg Oncol Clin N Am
; 20(3): 439-45, vii, 2011 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-21640913
17.
Randomized phase II neoadjuvant comparison between letrozole, anastrozole, and exemestane for postmenopausal women with estrogen receptor-rich stage 2 to 3 breast cancer: clinical and biomarker outcomes and predictive value of the baseline PAM50-based intrinsic subtype--ACOSOG Z1031.
J Clin Oncol
; 29(17): 2342-9, 2011 Jun 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-21555689
18.
How a surgeon in the boonies becomes a researcher and regional expert.
Bull Am Coll Surg
; 92(12): 33-4, 2007 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-18236621
Resultados
1 -
18
de 18
1
Próxima >
>>